S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma

Stopped early · Phase 2

Conditions studied: Multiple Myeloma, Plasmacytoma

In brief

RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI) and fludeoxyglucose F 18 positron emission tomography (\^18FDG-PET) may help diagnose solitary plasmacytoma. PURPOSE: This clinical trial is studying MRI and \^18FDG-PET to see how well they work in diagnosing patients with solitary plasmacytoma.

Key facts

Study ID
NCT00109889
Run by
SWOG Cancer Research Network
People needed
2
Starts
2005-04-01
Expected to finish
2007-04-01
Last updated by the study team
2017-04-24

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.